Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|
| translocation
|
|
|
rearranged in myxoid liposarcoma with translocation t(12;16) and in myeloid leukemia with translocation t(16;21)(q13;p11) | tumoral
| fusion
|
|
|
|
fused with ATF1 in t (12;16)(q13;p11) in angiomatoid fibrous histiocytomas and with DDIT3 in myxoid liposarcoma | tumoral
| fusion
|
|
|
|
fused with ERG in t(16;21)(p11;q22)in Ewing sarcoma | tumoral
| fusion
|
|
|
|
with CREB3L2 in t(7;16) (q33;p11 in fibromyxoid sarcoma, low-grade | constitutional
| germinal mutation
|
|
|
|
in ALS6, amyotrophic lateral sclerosis (R521G missense mutation in FUS/TLS led to aberrant trafficking with subsequent cytoplasmic retention of the mutant protein) | tumoral
|
|
| --over
|
|
in liposarcoma  | |